Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02369874
Title Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca

head and neck squamous cell carcinoma


Durvalumab + Tremelimumab


Age Groups: adult
Covered Countries USA

No variant requirements are available.